FDA
approval
· 2019-11-20
FDA Approved: DEFERASIROX — Original Application (Bionpharma Inc.)
Summary
FDA approved Deferasirox as the generic version under an Original Application (ANDA) submitted by Bionpharma Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for DEFERASIROX (DEFERASIROX)